Strategies to improve the EPR effect: A mechanistic perspective and clinical translation

M Ikeda-Imafuku, LLW Wang, D Rodrigues… - Journal of Controlled …, 2022 - Elsevier
Many efforts have been made to achieve targeted delivery of anticancer drugs to enhance
their efficacy and to reduce their adverse effects. These efforts include the development of …

Stimuli-responsive nano-architecture drug-delivery systems to solid tumor micromilieu: past, present, and future perspectives

HS El-Sawy, AM Al-Abd, TA Ahmed, KM El-Say… - ACS …, 2018 - ACS Publications
The microenvironment characteristics of solid tumors, renowned as barriers that harshly
impeded many drug-delivery approaches, were precisely studied, investigated, categorized …

Emerging nanotechnological approaches to regulating tumor vasculature for cancer therapy

C Wang, J Xu, Y Zhang, G Nie - Journal of Controlled Release, 2023 - Elsevier
Abnormal angiogenesis stands for one of the most striking manifestations of malignant
tumor. The pathologically and structurally abnormal tumor vasculature facilitates a hostile …

Modulating the tumor microenvironment to enhance tumor nanomedicine delivery

B Zhang, Y Hu, Z Pang - Frontiers in pharmacology, 2017 - frontiersin.org
Nanomedicines including liposomes, micelles, and nanoparticles based on the enhanced
permeability and retention (EPR) effect have become the mainstream for tumor treatment …

Nano-engineered mesenchymal stem cells increase therapeutic efficacy of anticancer drug through true active tumor targeting

B Layek, T Sadhukha, J Panyam, S Prabha - Molecular Cancer Therapeutics, 2018 - AACR
Tumor-targeted drug delivery has the potential to improve therapeutic efficacy and mitigate
non-specific toxicity of anticancer drugs. However, current drug delivery approaches rely on …

Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis

MA Subhan, F Parveen, N Filipczak… - Journal of personalized …, 2023 - mdpi.com
The innovative development of nanomedicine has promised effective treatment options
compared to the standard therapeutics for cancer therapy. However, the efficiency of EPR …

Anti-lymphangiogenesis for boosting drug accumulation in tumors

C Wang, J Xu, X Cheng, G Sun, F Li, G Nie… - Signal Transduction and …, 2024 - nature.com
The inadequate tumor accumulation of anti-cancer agents is a major shortcoming of current
therapeutic drugs and remains an even more significant concern in the clinical prospects for …

Precise fibrin decomposition and tumor mechanics modulation with hydroxyethyl starch-based smart nanomedicine for enhanced antitumor efficacy

J Chen, Z Zhang, Y Li, H Zeng, Z Li, C Wang… - Journal of Materials …, 2022 - pubs.rsc.org
Chemotherapy is a conventional cancer treatment in clinical settings. Although numerous
nano drug delivery systems have been developed, the chemotherapeutic effect is greatly …

PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models

L Morosi, M Meroni, P Ubezio, I Fuso Nerini… - Journal of Experimental …, 2021 - Springer
Background Scarce drug penetration in solid tumours is one of the possible causes of the
limited efficacy of chemotherapy and is related to the altered tumour microenvironment. The …

Stromal disruption facilitating invasion of a 'nano-arsenal'into the solid tumor

Y Fu, AL Saraswat, J Monpara, K Patel - Drug Discovery Today, 2022 - Elsevier
Owing to the indispensable role of nanotechnology in cancer therapy, it is imperative to
comprehend every aspect limiting its therapeutic potential. Several preclinical reports have …